Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dyslipidemia

Free Subscription Articles published in PLoS One Retrieve available abstracts of 109 articles: HTML format

Single Articles

January 2025
1. MIAO X, Li B, Zhu Z, Yang T, et al
   Sex differences in the association between composite dietary antioxidant index and hyperlipidemia: Insights from NHANES.
   PLoS One. 2025;20:e0316130.
   PubMed     Abstract available
   
   
   
2. MA M, Lv D, Wu X, Chen Y, et al
   Association between normal weight obesity and comorbidities and events of cardiovascular diseases among adults in South China.
   PLoS One. 2025;20:e0316346.
   PubMed     Abstract available
   
   
   
3. LEE JW, Lee H, Han E, Kang HY, et al
   Insignificant difference in medication adherence to dyslipidemia drugs between visually impaired and non-disabled people in South Korea: A nationwide cohort study using claims records.
   PLoS One. 2025;20:e0307764.
   PubMed     Abstract available
   
   
   
4. RASOOL A, Chidi C, Rigaut S, Carty S, et al
   A novel combinatorial approach integrating experimental and computational analysis of antioxidant activity: Evaluating catechin and L-ascorbic acid in serum.
   PLoS One. 2025;20:e0309881.
   PubMed     Abstract available
   
   
   
5. GAU TP, Wen JH, Lu IW, Huang PY, et al
   Application of attenuated total reflection-Fourier transform infrared spectroscopy in semi-quantification of blood lipids and characterization of the metabolic syndrome.
   PLoS One. 2025;20:e0316522.
   PubMed     Abstract available
   
   
   
6. NONTERAH EA, Agongo G, Crowther NJ, Mohamed SF, et al
   Obesity phenotypes and dyslipidemia in adults from four African countries: An H3Africa AWI-Gen study.
   PLoS One. 2025;20:e0316527.
   PubMed     Abstract available
   
   
   
7. XIANG M, Peng J, Gui Z, Jin J, et al
   Association of dietary niacin intake with all-cause mortality in chronic kidney disease: A retrospective cohort study of NHANES.
   PLoS One. 2025;20:e0313398.
   PubMed     Abstract available
   
   
   
8. FLOEGEL A, Russo P, Veidebaum T, Tornaritis M, et al
   Transition of clinical biomarker status from childhood into adolescence-A prospective study in children from eight European countries.
   PLoS One. 2025;20:e0311180.
   PubMed     Abstract available
   
   
   
9. YE R, Huang X, Yang H, Pan W, et al
   A predictive model to assess the risk of developing hyperlipidemia in patients with type 2 diabetes.
   PLoS One. 2025;20:e0315781.
   PubMed     Abstract available
   
   
   
10. PAN J, Liang J, Xue Z, Meng X, et al
    Effect of dietary anthocyanins on the risk factors related to metabolic syndrome: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0315504.
    PubMed     Abstract available
    
    
    
11. MEZHAL F, Ahmad A, Abdulle A, Leinberger-Jabari A, et al
    Association of family history of cardiovascular disease with the prevalence of cardiometabolic risk factors in young adults in the United Arab Emirates: The UAE healthy future study.
    PLoS One. 2025;20:e0319648.
    PubMed     Abstract available
    
    
    
12. KIM J, Park KA, Han K, Jung JH, et al
    Ocular motor cranial neuropathy and risk of thyroid cancer: A Korean population-based study.
    PLoS One. 2025;20:e0319872.
    PubMed     Abstract available
    
    
    
13. WANG Y, Feng S, Chen J, Li Y, et al
    Association between serum 25-hydroxyvitamin D concentration and the risk of colorectal cancer: A cross-sectional study.
    PLoS One. 2025;20:e0320335.
    PubMed     Abstract available
    
    
    
14. LI M, Hu X, Hu X, Gao F, et al
    Inhibition of PHB1/PHB2 suppresses atherosclerotic plaque formation by interrupting PI3K/AKT/mTOR signaling.
    PLoS One. 2025;20:e0320509.
    PubMed     Abstract available
    
    
    
15. LI Y, Liu X, Li Q, Zhou P, et al
    Association of helicobacter pylori infection with lipid metabolism and 10-year cardiovascular risk in diabetes mellitus: A cross-sectional study.
    PLoS One. 2025;20:e0319688.
    PubMed     Abstract available
    
    
    
16. SU Z, Ling Z, Chen H, Hu L, et al
    Association between hyperlipidemia and nephrolithiasis: A comprehensive bioinformatics analysis deciphering the potential common denominator pathogenesis.
    PLoS One. 2025;20:e0321734.
    PubMed     Abstract available
    
    
    
17. PARK J, Kim DY, Suh M, Kim YH, et al
    Assessing gastric cancer risk through longitudinal health check-up data: Insights from a national cohort study in South Korea.
    PLoS One. 2025;20:e0312861.
    PubMed     Abstract available
    
    
    
18. COLMENARES-MEJIA CC, Garcia-Suaza AF, Rodriguez-Lesmes P, Lochmuller C, et al
    Predicting diabetes mellitus metabolic goals and chronic complications transitions-analysis based on natural language processing and machine learning models.
    PLoS One. 2025;20:e0321258.
    PubMed     Abstract available
    
    
    
19. RASTOGI A, Ravindranath V, Dubey A, Gude D, et al
    A real-world multicenter cross-sectional observational study to assess the clinical profile of peripheral neuropathy in patients with diabetes.
    PLoS One. 2025;20:e0312085.
    PubMed     Abstract available
    
    
    
20. CHOI B, Kim K, Park HJ, Song YK, et al
    Onsite clinic utilization and adherence in semiconductor employees at chronic disease risk.
    PLoS One. 2025;20:e0321252.
    PubMed     Abstract available
    
    
    
21. ZELEKE TM, Liben FE, Tesfaye TS, Munea AL, et al
    Prevalence and associated factors of dyslipidemia among adults with coexisting chronic disease in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0320119.
    PubMed     Abstract available
    
    
    
22. ZHONG Q, Ren L, Wang T, An Z, et al
    The association between circadian syndrome and possible sarcopenia in an aging population: A 4-year follow-up study.
    PLoS One. 2025;20:e0323211.
    PubMed     Abstract available
    
    
    
23. CHOI J, Kim J, Oh HS
    Relationship between insulin resistance surrogate markers with diabetes and dyslipidemia: A Bayesian network analysis of Korean adults.
    PLoS One. 2025;20:e0323329.
    PubMed     Abstract available
    
    
    
24. SHI F, Yang D, Sun Q, Fang C, et al
    Association of the newly proposed dietary index for gut microbiota and hyperlipidemia: From the 2007-2020 NHANES study.
    PLoS One. 2025;20:e0323887.
    PubMed     Abstract available
    
    
    
25. KTEICH K, Karam MR, Zoghbi M, Aoun M, et al
    The impact of baseline laboratory tests on the management of new-onset hypertension in primary care: A pilot study.
    PLoS One. 2025;20:e0324743.
    PubMed     Abstract available
    
    
    
26. PARK H, Kang MK, Song TJ
    Association of renal hyperfiltration with incidence of dyslipidemia: a nationwide retrospective longitudinal cohort study.
    PLoS One. 2025;20:e0324710.
    PubMed     Abstract available
    
    
    
27. OZDEMIR F, Saglam M, Aksel Uylar AA, Uyaroglu OA, et al
    Could calisthenic exercises improve maximal exercise capacity, peripheral muscle strength and quality of life in dyslipidemia?
    PLoS One. 2025;20:e0326026.
    PubMed     Abstract available
    
    
    January 2024
28. ALBASSAM AA, Alenzi AN, Alhaqbani NK, Alhouty FK, et al
    Beliefs, awareness, use, and factors associated with herbal supplements usage among patients with chronic diseases-A cross-sectional insight from Alkharj, Saudi Arabia.
    PLoS One. 2024;19:e0295116.
    PubMed     Abstract available
    
    
    
29. ABD RAHIM IN, Mohd Kasim NA, Omar E, Abdul Muid S, et al
    Safety evaluation of saffron extracts in early and established atherosclerotic New Zealand white rabbits.
    PLoS One. 2024;19:e0295212.
    PubMed     Abstract available
    
    
    
30. LE-DANG MA, Nguyen-Thi HY, Dinh LP, Ngoc DL, et al
    Impact of COVID-19 on patterns of drug utilization: A case study at national hospital.
    PLoS One. 2024;19:e0297187.
    PubMed     Abstract available
    
    
    
31. LI Y, Gao H, Zhao J, Ma L, et al
    Safety and efficacy of bempedoic acid among patients with statin intolerance and those without: A meta-analysis and a systematic randomized controlled trial review.
    PLoS One. 2024;19:e0297854.
    PubMed     Abstract available
    
    
    
32. JUNG HH
    Blood pressure control in patients aged above and below 75 years.
    PLoS One. 2024;19:e0297103.
    PubMed     Abstract available
    
    
    
33. MATUTE I, Castillo-Laborde C
    Prescription drug coverage and effective coverage of three chronic conditions of high prevalence in Chile: Hypertension, diabetes and dyslipidemia.
    PLoS One. 2024;19:e0297807.
    PubMed     Abstract available
    
    
    
34. NAM DW, Park MH, Jeong SJ, Lee KL, et al
    Sex differences in associated factors for age-related hearing loss.
    PLoS One. 2024;19:e0298048.
    PubMed     Abstract available
    
    
    
35. LUTZHOFT DO, Baekgard C, Wimborne E, Straarup EM, et al
    High fat diet is associated with gut microbiota dysbiosis and decreased gut microbial derived metabolites related to metabolic health in young Gottingen Minipigs.
    PLoS One. 2024;19:e0298602.
    PubMed     Abstract available
    
    
    
36. LIU LP, Wariboko MA, Hu X, Wang ZH, et al
    Factors associated with early-onset androgenetic alopecia: A scoping review.
    PLoS One. 2024;19:e0299212.
    PubMed     Abstract available
    
    
    
37. XU S, Shiomi H, Yamashita Y, Koyama S, et al
    CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing.
    PLoS One. 2024;19:e0297231.
    PubMed     Abstract available
    
    
    
38. LUVIANO-GARCIA JA, Loose-Esparza A, Hernandez-Ruiz YG, Sanz-Sanchez MA, et al
    Risk factors for intubation and mortality in patients treated with high flow nasal cannula due to COVID-19 infection. Survival Analysis Study in a Northern Mexican Population.
    PLoS One. 2024;19:e0296931.
    PubMed     Abstract available
    
    
    
39. LEE T, Han K, Yun KI
    Association between dental scaling and metabolic syndrome and lifestyle.
    PLoS One. 2024;19:e0297545.
    PubMed     Abstract available
    
    
    
40. WEON B, Jang Y, Jo J, Jin W, et al
    Association between dyslipidemia and the risk of incident chronic kidney disease affected by genetic susceptibility: Polygenic risk score analysis.
    PLoS One. 2024;19:e0299605.
    PubMed     Abstract available
    
    
    
41. GHANEM AS, Nemeth O, More M, Nagy AC, et al
    Role of oral health in heart and vascular health: A population-based study.
    PLoS One. 2024;19:e0301466.
    PubMed     Abstract available
    
    
    
42. YAZDANI A, Mozaffarpur SA, Ebrahimi P, Shirafkan H, et al
    Comorbidities affecting re-admission and survival in COVID-19: Application of joint frailty model.
    PLoS One. 2024;19:e0301209.
    PubMed     Abstract available
    
    
    
43. CHOI E, Lee J, Choo E, Jang EJ, et al
    Continuity of care between dyslipidemia patients and multiple providers: A cohort study.
    PLoS One. 2024;19:e0300745.
    PubMed     Abstract available
    
    
    
44. BELETE AM, Melese DM, Bewket B, Tegegne B, et al
    Dyslipidemia among adult HIV patients on antiretroviral therapy and its association with age and body mass index in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298525.
    PubMed     Abstract available
    
    
    
45. HAO Y, Tang X, Xu F
    Association between hyperuricemia and the risk of mortality in patients with osteoarthritis: A study based on the National Health and Nutrition Examination Survey database.
    PLoS One. 2024;19:e0302386.
    PubMed     Abstract available
    
    
    
46. HAN SK, Seo MJ, Lee T, Kim MY, et al
    Effectiveness of the ALT/AST ratio for predicting insulin resistance in a Korean population: A large-scale, cross-sectional cohort study.
    PLoS One. 2024;19:e0303333.
    PubMed     Abstract available
    
    
    
47. ZHANG H, Fan Y, Li H, Feng X, et al
    Genetic association of serum lipids and lipid-modifying targets with endometriosis: Trans-ethnic Mendelian-randomization and mediation analysis.
    PLoS One. 2024;19:e0301752.
    PubMed     Abstract available
    
    
    
48. MIRZAMOHAMADI S, HajiAbbasi MN, Roshandel G, Alimadadi M, et al
    Incidence and risk factors of pancreatic cancer during 15 years follow-up in the Golestan Cohort Study in Iran.
    PLoS One. 2024;19:e0300736.
    PubMed     Abstract available
    
    
    
49. GUO L, Zhao P, Xue S, Zhu Z, et al
    Association of urinary bisphenol A with hyperlipidemia and all-cause mortality: NHANES 2003-2016.
    PLoS One. 2024;19:e0304516.
    PubMed     Abstract available
    
    
    
50. MONGKOLSUCHARITKUL P, Surawit A, Manosan T, Ophakas S, et al
    Metabolic and genetic risk factors associated with pre-diabetes and type 2 diabetes in Thai healthcare employees: A long-term study from the Siriraj Health (SIH) cohort study.
    PLoS One. 2024;19:e0303085.
    PubMed     Abstract available
    
    
    
51. LIN YW, Chen PC, Lin CH, Lin MH, et al
    Investigating medication adherence among Taiwanese patient with hypertension, hyperlipidemia, and diabetes: A pilot study using the Chinese version of a Two-Part Medication Nonadherence Scale and the NHI MediCloud system.
    PLoS One. 2024;19:e0304442.
    PubMed     Abstract available
    
    
    
52. YUAN S, Li L, Pu T, Fan X, et al
    The relationship between NLR, LDL-C/HDL-C, NHR and coronary artery disease.
    PLoS One. 2024;19:e0290805.
    PubMed     Abstract available
    
    
    
53. LIN L, Hu X, Liu X, Hu G, et al
    Key influences on dysglycemia across Fujian's urban-rural divide.
    PLoS One. 2024;19:e0308073.
    PubMed     Abstract available
    
    
    
54. ZHUANG Y, Wang Y, Sun P, Ke J, et al
    Association between blood lead, cadmium, selenium levels and hyperlipidemia: A population-based study.
    PLoS One. 2024;19:e0306573.
    PubMed     Abstract available
    
    
    
55. ABRAMS EJ, Jao J, Madlala HP, Zerbe A, et al
    An observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocol.
    PLoS One. 2024;19:e0307296.
    PubMed     Abstract available
    
    
    
56. AL-AZAYZIH A, Kanaan RJ, Altawalbeh SM, Alzoubi KH, et al
    Prevalence and predictors of hypoglycemia in older outpatients with type 2 diabetes mellitus.
    PLoS One. 2024;19:e0309618.
    PubMed     Abstract available
    
    
    
57. ARISI TOP, da Silva DS, Stein E, Weschenfelder C, et al
    Effects of cocoa consumption on cardiometabolic risk markers: Protocol for a systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0309824.
    PubMed     Abstract available
    
    
    
58. WANG Y, Yang Z, Li J, Wu Z, et al
    The risk of dyslipidemia on PLHIV associated with different antiretroviral regimens in Huzhou.
    PLoS One. 2024;19:e0305461.
    PubMed     Abstract available
    
    
    
59. KWAN ML, Pimentel N, Izano M, Iribarren C, et al
    Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study.
    PLoS One. 2024;19:e0310531.
    PubMed     Abstract available
    
    
    
60. SOLEIMANI N, Ebrahimi F, Mirzaei M
    Self-management education for hypertension, diabetes, and dyslipidemia as major risk factors for cardiovascular disease: Insights from stakeholders' experiences and expectations.
    PLoS One. 2024;19:e0310961.
    PubMed     Abstract available
    
    
    
61. XU DR, Gao X, Zhao LB, Liu SD, et al
    Association between triglyceride and depression: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0311625.
    PubMed     Abstract available
    
    
    
62. OH S, Cho KH, Kim MC, Sim DS, et al
    Ten-year trends in lipid management among patients after myocardial infarction in South Korea.
    PLoS One. 2024;19:e0304710.
    PubMed     Abstract available
    
    
    
63. BANANDUR PS, Sukumar GM, Arvind BA, P R S, et al
    Population-based cohort across stroke life course in India-The NIMHANS-NH-SKAN stroke project: A study protocol.
    PLoS One. 2024;19:e0310309.
    PubMed     Abstract available
    
    
    
64. HU YN, Wu M, Yu HP, Wu QY, et al
    Analysis of low-density lipoprotein receptor gene mutations in a family with familial hypercholesterolemia.
    PLoS One. 2024;19:e0310547.
    PubMed     Abstract available
    
    
    
65. ASADI-ALIABADI M, Karimi SM, Mirbaha-Hashemi F, Tehrani-Banihashemi A, et al
    The effect of results-based motivating system on metabolic risk factors of non-communicable diseases: A field trial study.
    PLoS One. 2024;19:e0311507.
    PubMed     Abstract available
    
    
    
66. ZHAO M, Zhang Q, Lin Y, Zhang D, et al
    The association between dietary carbohydrate intake and the risk of hyperlipidemia among reproductive-aged women in the US: A cross-sectional study.
    PLoS One. 2024;19:e0310184.
    PubMed     Abstract available
    
    
    
67. DELBARI A, Naderyan Feli S, Amirabadizadeh AR, Niroomand M, et al
    Prevalence and associated factors of dyslipidemia in elderly people: Results from the Ardakan Cohort Study on Ageing, Iran.
    PLoS One. 2024;19:e0306388.
    PubMed     Abstract available
    
    
    
68. JIA F, Sun J, Liu X, Liu Y, et al
    Life Essentials 8 score and risk of metabolic syndrome: A dose-response analysis in the US population.
    PLoS One. 2024;19:e0312674.
    PubMed     Abstract available
    
    
    
69. LIU L, Deng Y, Li L, Yang X, et al
    Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis.
    PLoS One. 2024;19:e0310696.
    PubMed     Abstract available
    
    
    
70. CHAPAGAIN S, Pathak N, Subedi K, Ghimire P, et al
    Drug-related problems among type 2 diabetic patients in Sunwal Municipality of Western Nepal.
    PLoS One. 2024;19:e0309781.
    PubMed     Abstract available
    
    
    
71. MARIC GD, Pekmezovic TD, Tamas OS, Veselinovic ND, et al
    Investigation of differences between chronological and vascular age in persons with multiple sclerosis.
    PLoS One. 2024;19:e0311117.
    PubMed     Abstract available
    
    
    
72. NGUYEN CQ, Pham TTP, Phan DC, Do HT, et al
    Cohort profile of a prospective cohort study among middle-aged community-dwellers in rural Vietnam: The Khanh Hoa cardiovascular study.
    PLoS One. 2024;19:e0312525.
    PubMed     Abstract available
    
    
    
73. BLOKHINA AV, Ershova AI, Kiseleva AV, Sotnikova EA, et al
    Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study.
    PLoS One. 2024;19:e0315693.
    PubMed     Abstract available
    
    
    
74. YANG T, Li W, Chen W, Zhu D, et al
    Protocol for a systematic review and meta-analysis of the combination of ezetimibe and statins for hyperlipidemia.
    PLoS One. 2024;19:e0312588.
    PubMed     Abstract available
    
    
    January 2023
75. DE OLIVEIRA CM, Bolognese LB, Balcells M, Aragon DC, et al
    A data-driven approach to manage type 2 diabetes mellitus through digital health: The Klivo Intervention Program protocol (KIPDM).
    PLoS One. 2023;18:e0281844.
    PubMed     Abstract available
    
    
    
76. LUI G, Leung HS, Lee J, Wong CK, et al
    An efficient approach to estimate the risk of coronary artery disease for people living with HIV using machine-learning-based retinal image analysis.
    PLoS One. 2023;18:e0281701.
    PubMed     Abstract available
    
    
    
77. ALAHMAD MM, ZainAlAbdin S, AlAhmad K, AlAhmad I, et al
    Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management.
    PLoS One. 2023;18:e0283369.
    PubMed     Abstract available
    
    
    
78. OHN K, Han K, Moon JI, Jung Y, et al
    Presence and severity of migraine is associated with development of primary open angle glaucoma: A population-based longitudinal cohort study.
    PLoS One. 2023;18:e0283495.
    PubMed     Abstract available
    
    
    
79. SONG DK, Hong YS, Sung YA, Lee H, et al
    The effect of menopause on cardiovascular risk factors according to body mass index in middle-aged Korean women.
    PLoS One. 2023;18:e0283393.
    PubMed     Abstract available
    
    
    
80. JO EJ, Lee YU, Kim A, Park HK, et al
    The prevalence of multiple chronic conditions and medical burden in asthma patients.
    PLoS One. 2023;18:e0286004.
    PubMed     Abstract available
    
    
    
81. MORI Y, Matsushita K, Inoue K, Fukuma S, et al
    Patterns and predictors of adherence to follow-up health guidance invitations in a general health check-up program in Japan: A cohort study with an employer-sponsored insurer database.
    PLoS One. 2023;18:e0286317.
    PubMed     Abstract available
    
    
    
82. SHIN H, Shim S, Oh S
    Machine learning-based predictive model for prevention of metabolic syndrome.
    PLoS One. 2023;18:e0286635.
    PubMed     Abstract available
    
    
    
83. SAPKOTA BP, Baral KP, Rehfuess EA, Parhofer KG, et al
    Effects of age on non-communicable disease risk factors among Nepalese adults.
    PLoS One. 2023;18:e0281028.
    PubMed     Abstract available
    
    
    
84. CHANG KC, Pai YW, Lin CH, Lee IT, et al
    The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.
    PLoS One. 2023;18:e0287373.
    PubMed     Abstract available
    
    
    
85. CHEN PT, Zhang HW, Tsai ZR, Peng HC, et al
    Association between hyperlipidemia and trigger finger: A nationwide population-based cohort study.
    PLoS One. 2023;18:e0288426.
    PubMed     Abstract available
    
    
    
86. BHANDARI P
    Prevalence of cardiovascular risk factors among Asian migrant workers in South Korea.
    PLoS One. 2023;18:e0288375.
    PubMed     Abstract available
    
    
    
87. VAINSHELBOIM B, Myers J
    Dyslipidemia paradox: Analysis from the veterans exercise testing study.
    PLoS One. 2023;18:e0287923.
    PubMed     Abstract available
    
    
    
88. ZHANG J, Olsen A, Halkjaer J, Petersen KE, et al
    Self-reported and measured anthropometric variables in association with cardiometabolic markers: A Danish cohort study.
    PLoS One. 2023;18:e0279795.
    PubMed     Abstract available
    
    
    
89. BOROWIEC A, Ozdowska P, Rosinska M, Jagiello-Gruszfeld A, et al
    Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC study.
    PLoS One. 2023;18:e0288146.
    PubMed     Abstract available
    
    
    
90. BERHE KK, Mselle LT, Gebru HB
    The magnitude of chronic diabetes complications and its associated factors among diabetic patients attending the general hospitals in Tigray region, Northern Ethiopia.
    PLoS One. 2023;18:e0290240.
    PubMed     Abstract available
    
    
    
91. ALJEHANI R, Aljehani G, Alharazi H, Horta PM, et al
    The Mediterranean Diet Scale (MDS): Translation and validation of the Arabic version.
    PLoS One. 2023;18:e0287497.
    PubMed     Abstract available
    
    
    
92. XU S, Yang X, Liu J, Chong MK, et al
    Health and wellbeing among the empty nest and non-empty nest elderly in China-Results from a national cross-sectional study.
    PLoS One. 2023;18:e0291231.
    PubMed     Abstract available
    
    
    
93. HEERKENS L, van Kleef LA, de Knegt RJ, Voortman T, et al
    Fatty Liver Index and mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort.
    PLoS One. 2023;18:e0287467.
    PubMed     Abstract available
    
    
    
94. ISMAIL FF, Md Redzuan A, Chong WW, Ahmad Nizaruddin M, et al
    Role of community pharmacists in cardiovascular diseases-related health promotion and dyslipidemia management in Malaysia: A nationwide cross-sectional study.
    PLoS One. 2023;18:e0290883.
    PubMed     Abstract available
    
    
    
95. NISHIDA Y, Anzai T, Takahashi K, Kozuma T, et al
    Multimorbidity patterns in the working age population with the top 10% medical cost from exhaustive insurance claims data of Japan Health Insurance Association.
    PLoS One. 2023;18:e0291554.
    PubMed     Abstract available
    
    
    
96. COSTA S, Guerreiro J, Teixeira I, Helling DK, et al
    Patient preferences and cost-benefit of hypertension and hyperlipidemia collaborative management model between pharmacies and primary care in Portugal: A discrete choice experiment alongside a trial (USFarmacia(R)).
    PLoS One. 2023;18:e0292308.
    PubMed     Abstract available
    
    
    
97. YADEGAR A, Mohammadi F, Rabizadeh S, Meysamie A, et al
    Decreasing trend of blood lipid profile in type 2 diabetes: Not a promising change in HDL-C, a serial cross-sectional study.
    PLoS One. 2023;18:e0293410.
    PubMed     Abstract available
    
    
    
98. SISCART J, Perejon D, Serna MC, Oros M, et al
    Prevalence, risk factors, and consequences of hypothyroidism among pregnant women in the health region of Lleida: A cohort study.
    PLoS One. 2023;18:e0278426.
    PubMed     Abstract available
    
    
    
99. MOTUMA A, Shiferaw K, Gobena T, Teji Roba K, et al
    Dyslipidemia and its predictors among adult workers in eastern Ethiopia: An institution-based cross-sectional study.
    PLoS One. 2023;18:e0291665.
    PubMed     Abstract available
    
    
    
100. SAKSERANEE J, Sethabouppha P, Pattarasakulchai T, Klaewkla T, et al
     The diagnostic tests and functional outcomes of acute ischemic stroke or transient ischemic attack in young adults: A 4-year hospital-based observational study.
     PLoS One. 2023;18:e0292274.
     PubMed     Abstract available
     
     
     
101. DIDEVAR N, Rezasoltani P, Pourgholaminejad A, Kazemnezhad Leyli E, et al
     Interleukin-17, C-reactive protein, Neutrophil-to-Lymphocyte ratio, Lymphocyte-to-Monocyte ratio, and lipid profiles in healthy menopausal women with or without hot flashes: A cross-sectional study.
     PLoS One. 2023;18:e0291804.
     PubMed     Abstract available
     
     
     
102. ALAHDAB F, El Shawi R, Ahmed AI, Han Y, et al
     Patient-level explainable machine learning to predict major adverse cardiovascular events from SPECT MPI and CCTA imaging.
     PLoS One. 2023;18:e0291451.
     PubMed     Abstract available
     
     
     
103. SINGLETON CMH, Brar S, Robertson N, DiTommaso L, et al
     Cardiometabolic risk factors in South American children: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0293865.
     PubMed     Abstract available
     
     
     
104. JIA X, Zhang X, Zhou T, Sun D, et al
     Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China.
     PLoS One. 2023;18:e0295184.
     PubMed     Abstract available
     
     
     
105. HARMADHA WSP, Muharram FR, Gaspar RS, Azimuth Z, et al
     Explaining the increase of incidence and mortality from cardiovascular disease in Indonesia: A global burden of disease study analysis (2000-2019).
     PLoS One. 2023;18:e0294128.
     PubMed     Abstract available
     
     
     
106. BADACHO AS, Mahomed OH
     Mapping evidence on barriers to and facilitators of diagnosing noncommunicable diseases (NCDs) among people living with human immunodeficiency virus (PLWH) in low- and middle-income countries (LMICs) in Africa: A scoping review protocol.
     PLoS One. 2023;18:e0294979.
     PubMed     Abstract available
     
     
     
107. FU W, Hu F, Xu C
     Association between red blood cell distribution width/albumin ratio and all-cause mortality or cardiovascular diseases mortality in patients with diabetic retinopathy: A cohort study.
     PLoS One. 2023;18:e0296019.
     PubMed     Abstract available
     
     
     January 2021
108. BUSCH C, Katzmann JL, Jochmann C, Unterlauft JD, et al
     General health of patients with diabetic macular edema-The LIPSIA study.
     PLoS One. 2021;16:e0252321.
     PubMed     Abstract available
     
     
     
109. DIECI M, Llibre-Rodriguez JJ, Acosta D, Dow WH, et al
     Cuba's cardiovascular risk factors: International comparison of levels and education gradients.
     PLoS One. 2021;16:e0247831.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.